Alcon Q3 net income rises 10% to $260 million; sales climb 5% to $2.7 billion

ALC•2026-11-10

Alcon’s third-quarter 2026 net income rose 10% year over year to $260 million, while net sales increased 5% to $2.7 billion.

1. Quarterly results

Alcon reported third-quarter 2026 net income of $260 million, up 10% year over year, and net sales of $2.7 billion, up 5%. For the first nine months of 2026, net income fell 41% to $449 million, including a $402 million charge for discontinuing PowerVision programs.

2. Retinal capabilities

Alcon said its recently announced acquisition of Neurotech Pharmaceuticals strengthens its retinal-disease capabilities with ENCELTO.

Sources

Alcon Q3 net income rises 10% to $260 million; sales climb 5% to $2.7 billion

Docs

Alcon Q3 net income rises 10% to $260 million; sales climb 5% to $2.7 billion

1. Quarterly results

2. Retinal capabilities

Related News

Floor & Decor EVP Ersan Sayman reports sale of $1.11 million in shares

Ultra Clean names Bryan Dennis chief accounting officer effective Nov. 13

Canada has not decided whether to lift Arctic drilling ban, Carney says

Sources

Alcon Q3 net income rises 10% to $260 million; sales climb 5% to $2.7 billion

Cosmos Health clarifies 1-for-20 reverse stock split takes effect Nov. 13, 2026

Atara Biotherapeutics prospectus covers up to $200 million in securities